Antineoplastics are medications which combat and inhibit abnormal proliferation of cells known as neoplasms or in chemotherapy.
Categories
Alkylating Antineoplastic AgentsAntimetaboliteAntineoplastic AntibioticsAntineoplastic Detoxifying Agents | Antineoplastic InterferonsMitotic InhibitorsMonoclonal Antibodies |
 
 
Recommended Resources
The company site for Afinitor tablets outlines data about the product including its use for treatment of advanced renal cell carcinoma, press releases, and a video about the agent, as well as information about how to go about getting reimbursement and assistance.
http://www.afinitor.com/index.jsp
The official site of Evista, makers of raloxifene, discusses the effectiveness of the tablets, bone and breast risk factors, and other resources.
http://www.evista.com/
Gleevec (matnib mesylate) is the topic of this web site which dispenses information about the use of the agent for treatment of Ph+ chronic myeloid leukemia and Kit+ gastrointestinal stromal tumors, frequently asked questions and off-site patient resources.
http://www.gleevec.com/index.jsp
Novartis’s Afinitor Pill May Be ‘Mega-Blockbuster’
Bloomberg article delves into Afinitor and its effects on renal cell carcinoma as well as possibilities of successful treatment of lymphoma, lung, breast, and gastric cancers.
http://www.bloomberg.com/apps/news?pid=20601085&sid=aTZcqX.wysVQ
Occupational Exposure to Antineoplastic Agents
The National Institute for Occupational Safety and Health article outlines hazards which are associated with exposure to the chemotherapy agent. Those who are at risk include physicians, nurses, and other health care workers, as well as hospital janitorial staff and laundry workers.
http://www.cdc.gov/niosh/topics/antineoplastic/
Offers information for consumers in the U.S. from Bristol-Myers Squibb.
http://www.sprycel.com
Tamoxifen: Questions and Answers
National Cancer Institute's fact sheet answers common questions about tamoxifen, brand name Nolvadex, including how it works, how long it should be taken, common side effects, and a comparison to raloxifene.
http://www.cancer.gov/cancertopics/factsheet/Therapy/tamoxifen
Details the use of Tarceva for advanced non-small cell lung cancer including the indication for usage for lung and pancreatic cancer patients and contains detailed sections for each of the two approved cancers it treats.
http://www.tarceva.com/index.jsp